ESTEVE QUIM S A has a total of 12 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), South Africa and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ORIDIGM CORP, SCINOPHARM CHANGSHU PHARMACEUTICALS LTD and FARMOS GROUP LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | South Africa | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | Hungary | 1 | |
#6 | Tunisia | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Berenguer Maimó Ramón | 4 |
#2 | Winter Stephen Benedict David | 4 |
#3 | Berenguer Maimo Ramon | 4 |
#4 | Li Pixu | 3 |
#5 | Wei Qiang | 3 |
#6 | Bartra Sanmarti Marti | 3 |
#7 | Wang Peng | 3 |
#8 | Liu Yuanhua | 3 |
#9 | Sola I Carandell Lluis | 2 |
#10 | Benet-Buchholz Jordi | 2 |
Publication | Filing date | Title |
---|---|---|
EP3363798A1 | Amorphous form of telotristat etiprate | |
EP3318568A1 | Preparation process of edoxaban tosylate monohydrate | |
US2018155284A1 | Processes to produce brivaracetam |